Pharma 5.0

Artificial intelligence in pharmaceutical inspection: improving quality with better algorithms

Published: 18-Jun-2026

ROVIS helps pharmaceutical manufacturers to improve inspection quality, reduce false rejects and cut waste with robotics, advanced software and AI

You need to be a subscriber to read this article.
Click here to find out more.

The inspection of parenteral products is essential in pharmaceutical manufacturing. Every container leaving a facility must meet strict quality standards to ensure patient safety and maintain efficient production.

Discussions about visual inspection often emphasise the physical system components, including cameras, lighting, container handling and increasingly sophisticated robotics.

However, the true intelligence of a modern inspection system lies in its software, where much of the development effort and value are concentrated.

Container handling and positioning 

The process begins with container handling. Before inspection, products must be positioned correctly. Automated systems manage containers differently from human inspectors, who naturally manipulate them to maximise defect visibility. 

Artificial intelligence in pharmaceutical inspection: improving quality with better algorithms

Modern robotic systems increasingly replicate these movements, bringing key benefits of manual inspection into automated environments. 

Image acquisition 

Next comes image acquisition. Human inspectors build visual understanding by examining containers against white and black backgrounds.

Automated systems achieve the same objective with carefully designed lighting and camera configurations to capture images from multiple angles and under different conditions.  

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
  2. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like